Combination antiretroviral therapy and the risk of myocardial infarction

被引:1289
作者
Friis-Moller, N [1 ]
Sabin, CA [1 ]
Weber, R [1 ]
Monforte, AD [1 ]
El-Sadr, WM [1 ]
Reiss, P [1 ]
Thiébaut, R [1 ]
Morfeldt, L [1 ]
De Wit, S [1 ]
Pradier, C [1 ]
Calvo, G [1 ]
Law, MG [1 ]
Kirk, O [1 ]
Phillips, AN [1 ]
Lundgren, JD [1 ]
Lundgren, JD [1 ]
Weber, R [1 ]
Monteforte, AD [1 ]
Bartsch, G [1 ]
Reiss, P [1 ]
Dabis, F [1 ]
Morfeldt, L [1 ]
De Wit, S [1 ]
Pradier, C [1 ]
Calvo, G [1 ]
Law, MG [1 ]
Kirk, O [1 ]
Phillips, AN [1 ]
Houyez, F [1 ]
Loeliger, E [1 ]
Tressler, R [1 ]
Weller, I [1 ]
Friis-Moller, N [1 ]
Sabin, CA [1 ]
Sjol, A [1 ]
Lundgren, JD [1 ]
Sawitz, A [1 ]
Rickenbach, M [1 ]
Pezzotti, P [1 ]
Krum, E [1 ]
Meester, R [1 ]
Lavignolle, V [1 ]
Sundström, A [1 ]
Poll, B [1 ]
Fontas, E [1 ]
Torres, F [1 ]
Petoumenos, K [1 ]
Kjær, J [1 ]
Hammer, S [1 ]
Neaton, J [1 ]
机构
[1] Hvidovre Univ Hosp, Sect 044, Copenhagen HIV Program, DAD Coordinating Ctr, DK-2650 Copenhagen, Denmark
关键词
D O I
10.1056/NEJMoa030218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. Methods: In this prospective observational study, we enrolled 23,468 patients from 11 previously established cohorts from December 1999 to April 2001 and collected follow-up data until February 2002. Data were collected on infection with the human immunodeficiency virus and on risk factors for and the incidence of myocardial infarction. Relative rates were calculated with Poisson regression models. Combination antiretroviral therapy was defined as any combination regimen of antiretroviral drugs that included a protease inhibitor or a nonnucleoside reverse transcriptase inhibitor. Results: Over a period of 36,199 person-years, 126 patients had a myocardial infarction. The incidence of myocardial infarction increased with longer exposure to combination antiretroviral therapy (adjusted relative rate per year of exposure, 1.26 [95 percent confidence interval, 1.12 to 1.41]; P<0.001). Other factors significantly associated with myocardial infarction were older age, current or former smoking, previous cardiovascular disease, and male sex, but not a family history of coronary heart disease. A higher total serum cholesterol level, a higher triglyceride level, and the presence of diabetes were also associated with an increased incidence of myocardial infarction. Conclusions: Combination antiretroviral therapy was independently associated with a 26 percent relative increase in the rate of myocardial infarction per year of exposure during the first four to six years of use. However, the absolute risk of myocardial infarction was low and must be balanced against the marked benefits from antiretroviral treatment.
引用
收藏
页码:1993 / 2003
页数:11
相关论文
共 30 条
  • [1] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [2] Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
    Berenson, GS
    Srinivasan, SR
    Bao, WH
    Newman, WP
    Tracy, RE
    Wattigney, WA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) : 1650 - 1656
  • [3] Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
    Bozzette, SA
    Ake, CF
    Tam, HK
    Chang, SW
    Louis, TA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08) : 702 - 710
  • [4] An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
    Carr, A
    Emery, S
    Law, I
    Puls, R
    Lundgren, JD
    Powderly, WG
    Carr, B
    Cooper, DA
    Grinspoon, S
    Ioannidis, J
    Lewis, R
    Law, M
    Lichtenstein, K
    Murray, J
    Pizzuti, D
    Rozenbaum, W
    Schambelan, M
    Moore, A
    Miller, J
    [J]. LANCET, 2003, 361 (9359) : 726 - 735
  • [5] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
    Carr, A
    Samaras, K
    Thorisdottir, A
    Kaufmann, GR
    Chisholm, DJ
    Cooper, DA
    [J]. LANCET, 1999, 353 (9170) : 2093 - 2099
  • [6] Adverse effects of antiretroviral therapy
    Carr, A
    Cooper, DA
    [J]. LANCET, 2000, 356 (9239) : 1423 - 1430
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: An analysis of four different protease inhibitors
    Coplan, PM
    Nikas, A
    Japour, A
    Cormier, K
    Maradit-Kremers, H
    Lewis, R
    Xu, Y
    DiNubile, MJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (06) : 449 - 455
  • [9] Currier J, 2002, ANTIVIR THER, V7, pL37
  • [10] *D A D STUD, DAT COLL ADV EV ANT